Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$700K Buy
+3,239
New +$620K 0.01% 2116
2026
Q1
Sell
-2,459
Closed -$433K 3852
2025
Q4
$433K Buy
+2,459
New +$402K 0.01% 1735
2025
Q2
Sell
-16,743
Closed -$2.29M 2382
2025
Q1
$2.29M Buy
16,743
+14,459
+633% +$2.07M 0.12% 209
2024
Q4
$349K Sell
2,284
-4,671
-67% -$788K 0.03% 1088
2024
Q3
$1.35M Buy
+6,955
New +$1.46M 0.1% 296
2024
Q2
Sell
-7,176
Closed -$1.55M 1879
2024
Q1
$1.55M Buy
7,176
+4,036
+129% +$945K 0.21% 61
2023
Q4
$813K Buy
3,140
+1,021
+48% +$251K 0.18% 63
2023
Q3
$545K Sell
2,119
-265
-11% -$70.9K 0.09% 347
2023
Q2
$679K Buy
+2,384
New +$710K 0.12% 222
2023
Q1
Sell
-830
Closed -$230K 1276
2022
Q4
$230K Sell
830
-543
-40% -$153K 0.05% 758
2022
Q3
$367K Sell
1,373
-1,144
-45% -$243K 0.09% 382
2022
Q2
$513K Buy
2,517
+512
+26% +$105K 0.21% 108
2022
Q1
$422K Buy
2,005
+1,148
+134% +$250K 0.19% 182
2021
Q4
$206K Sell
857
-1,643
-66% -$422K 0.12% 360
2021
Q3
$707K Buy
+2,500
New +$819K 0.24% 99

Other funds holding BIIB

XTX Topco's BIIB Position: Q2 2026 in Review

XTX Topco opened a new position in Biogen (BIIB) in Q2 2026: 3,239 shares worth $700K. The stake represents 0.01% of the portfolio and ranks #2116 among its holdings. This is a return to the name: XTX Topco previously reported a position in BIIB as recently as Q4 2025.

XTX Topco first reported a position in BIIB in Q3 2021 and has held it in 15 quarters since. The position peaked at $2.29M in Q1 2025. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • XTX Topco held 3,239 shares of Biogen worth $700K as of Q2 2026.
  • Biogen was a new XTX Topco position in Q2 2026.
  • Biogen made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2116 holding.
  • XTX Topco first reported a position in Biogen in Q3 2021 and has held it in 15 quarters since.
  • XTX Topco's Biogen position peaked at $2.29M in Q1 2025.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.